J-EG-M declares that he has received honoraria for lectures for AstraZeneca, Bayer, Boheringer Ingelheim, Merck, and Xinetixs Pharma
Medicaid coverage All state Medicaid programs cover GLP-1s for type 2 diabetes, but weight loss coverage is optional and left to each state
Epigenetic transgenerational inheritance of obesity susceptibility
To understand who is actually a candidate and what monitoring looks like, see our expert review of whether peptides are safe for weight loss, including who is a candidate, what monitoring matters, and the right questions to ask a licensed provider
This groundbreaking GLP-1 pill for weight loss is highly effective, achieving an average of 16.6% body weight loss in trials